NanoString Technologies Inc (NSTG)

Overview

NanoString Technologies, Inc. is a pioneer in the fields of genomics and proteomics, offering cutting-edge technology solutions for scientific and clinical research across the Americas, Europe, the Middle East, and the Asia Pacific. Founded in 2003 and based in Seattle, Washington, the company has dedicated itself to developing, manufacturing, and selling automated systems for digital detection and counting, enhancing the way researchers and clinicians gather and interpret complex biological information. However, financial challenges led to NanoString Technologies, Inc. filing for Chapter 11 bankruptcy reorganization on February 4, 2024, marking a significant turn in its operational journey.

Products and Services

• nCounter Analysis System - An automated, multi-application platform for digital detection and counting, capable of handling various scientific applications. It comprises two key components:
  • Prep Station - An automated liquid handling component that processes and prepares samples for data collection.
  • nCounter Digital Analyzer - Collects data from samples through imaging of immobilized fluorescent reporters in the sample cartridge, processing the data into output files.
• nCounter Pro and FLEX Systems - Advanced versions of the nCounter system, designed for high-throughput needs, including the necessary kits and reagents for sample processing.
• nCounter SPRINT Profiler - A streamlined instrument providing both liquid handling and digital analysis in a microfluidic cartridge format, designed for rapid analysis.
• nSolver Analysis Software - A comprehensive data analysis program that enables researchers to check, normalize, and analyze their data efficiently.
• Custom CodeSets and Panels - Customizable gene and protein panels tailored for specific research needs, covering areas such as oncology, immunology, infectious disease, and neuroscience applications.
• Master Kits, Cartridges, and Ancillary Reagents - Essential consumables and reagents designed for use with NanoString’s various systems for optimal performance.
• Prosigna In Vitro Diagnostic Kits - Diagnostic kits that offer a deeper understanding of cancer biology for more personalized patient care.
• GeoMx DSP System - In development, this system aims to pioneer the field of spatial biology by providing detailed spatial profiling of biological tissues.
• Strategic Collaborations - Partnerships with institutions such as Lam Research Corporation, the Parker Institute for Cancer Immunotherapy, Stanford Medicine, Acrobat Genomics, and Illumina Accelerator, focusing on developing next-generation sequencing platforms, improving cancer treatment regimens, and discovering new drug targets for gene editing-based therapeutics.